Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada (summary)

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 12, 2010, Pages 1315-1319

  Hanley, David A ^a   Cranney, Ann ^b   Jones, Glenville ^c   Whiting, Susan J ^d   Leslie, William D ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; COLECALCIFEROL; VITAMIN D; 25-HYDROXYVITAMIN D;

BONE DENSITOMETRY; CANADA; CLINICAL TRIAL; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; FALLING; FRACTURE; HIP FRACTURE; HUMAN; MUSCLE STRENGTH; OSTEOPOROSIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; REVIEW; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ADULT; ANALOGS AND DERIVATIVES; BLOOD; BONE DENSITY; COMPLICATION; DIET SUPPLEMENTATION; DRUG EFFECTS; FRACTURES, BONE; METABOLISM; NUTRITIONAL REQUIREMENT; PHYSIOLOGY; SUNLIGHT;

ADULT; BONE DENSITY; DIETARY SUPPLEMENTS; FRACTURES, BONE; HUMANS; NUTRITIONAL REQUIREMENTS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77956409196     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.091062     Document Type: Article

References (51)

1. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(Suppl):S1-34.
2. Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington (DC): National Academy Press; 1997.
3. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.
4. Hanley DA, Cranney A, Jones G, et al. Vitamin D in adult health and disease: a review and guideline statement from osteoporosis Canada. CMAJ 2010. DOI 10.1503/cmaj.080663.
5. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
6. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008;88:582S-6S.
7. 3 in humans. J Clin Endocrinol Metab 2004;89:5387-91.
8. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004;89:3152-7. (Pubitemid 38951877)
9. Jones G, Horst R, Carter G, et al. Contemporary diagnosis and treatment of vitamin D-related disorders. J Bone Miner Res 2007;22(Suppl 2):V11-5.
10. Lips P, Chapuy MC, Dawson-Hughes B, et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999;9:394-7. (Pubitemid 29231730)
11. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10.
12. 3 supplementation regimens. J Bone Miner Res 2007;22(Suppl 1):S126.
13. Gaugris S, Heaney RP, Boonen S, et al. Vitamin D inadequacy among postmenopausal women: a systematic review. QJM 2005;98:667-76. (Pubitemid 41236096)
14. Weatherall M. A meta-analysis of 25 hydroxyvitamin D in older people with fracture of the proximal femur. N Z Med J 2000;113:137-40.
15. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-22.
16. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(Suppl):1678S-88S.
17. Roth DE, Martz P, Yeo R, et al. Are national vitamin D guidelines sufficient to maintain adequate blood levels in children? Can J Public Health 2005;96:443-9. (Pubitemid 41762919)
18. Rucker D, Allan JA, Fick GH, et al. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002;166:1517-24. (Pubitemid 34634371)
19. Vieth R, Cole DE, Hawker GA, et al. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001;55:1091-7. (Pubitemid 33114682)
20. Freedman DM, Looker AC, Chang SC, et al. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594-602.
21. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-28. (Pubitemid 44699167)
22. Hathcock JN, Shao A, Vieth R, et al. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18.
23. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116:634-9.
24. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-6.
25. Stone K, Bauer DC, Black DM, et al. Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1998;13:1167-74.
26. 3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19:1221-30.
27. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
28. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
29. 3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257-64.
30. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.
31. 3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-8.
32. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64.
33. Chung M, Balk EM, Brendel M, et al. Vitamin D and calcium: a systematic review of health outcomes. Evidence Report/Technology Assessment 183. AHRQ Publ. 07-E015. Rockville (MD): Agency for Healthcare Research and Quality; 2009.
34. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥ 60 y. Am J Clin Nutr 2004;80:752-8.
35. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006;166:424-30.
36. Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234-9.
37. Flicker L, MacInnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005;53:1881-8.
38. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.
39. Masuda S, Jones G. Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther 2006;5:797-808.
40. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61.
41. Gorham ED, Garland CF, Garland FC, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005;97:179-94.
42. Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-23.
43. Brown SJ. The role of vitamin D in multiple sclerosis. Ann Pharmacother 2006;40:1158-61.
44. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-3.
45. Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia 2005;48:1247-57.
46. Lucas R, McMichael T, Smith W, et al. Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation. Geneva (Switzerland): World Health Organization; 2006.
47. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia, Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182:281-5.
48. Webb AR. Who, what, where and when - influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006;92:17-25.
49. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 2009;24:935-42.
50. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:551-61.
51. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8.